Prelude Capital Management’s Opus Genetics, Inc. Common Stock IRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,110
| Closed | -$15.9K | – | 1502 |
|
|
2024
Q3 | $15.9K | Sell |
12,110
-1,742
| -13% | -$2.28K | ﹤0.01% | 1130 |
|
|
2024
Q2 | $21.2K | Sell |
13,852
-6,766
| -33% | -$10.4K | ﹤0.01% | 1078 |
|
|
2024
Q1 | $41.4K | Sell |
20,618
-6,059
| -23% | -$12.2K | ﹤0.01% | 1147 |
|
|
2023
Q4 | $80.3K | Buy |
26,677
+8,681
| +48% | +$26.1K | 0.01% | 914 |
|
|
2023
Q3 | $60.3K | Buy |
+17,996
| New | +$60.3K | ﹤0.01% | 891 |
|
|
2022
Q3 | – | Sell |
-17,802
| Closed | -$34K | – | 1834 |
|
|
2022
Q2 | $34K | Sell |
17,802
-10,441
| -37% | -$19.9K | ﹤0.01% | 1283 |
|
|
2022
Q1 | $92K | Sell |
28,243
-24,220
| -46% | -$78.9K | ﹤0.01% | 1139 |
|
|
2021
Q4 | $196K | Buy |
+52,463
| New | +$196K | 0.01% | 1232 |
|